Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-227

you know something I know we all think we are warren Buffett, but I think it is time that we have a good look in mirror and realise that we are not even close. in fact we are not even WB's toe rag.
Let's just start by really having a look at the figures and what they are telling us. Since 2014 earnings have grown from 32 cents to 92 cents ie a growth rate of only 14%
ROE has always been good around 20. But actual growth is around 14% and this company was on a PE of 30, way over valued compared to what the actual growth has been.
why? the number of people with sleep apnea and perceived market for CPAP machines
but now we have weight lose drugs
Now the question we need to ask ourselves is it likely that RMD will ever have growth rate of 30% as implied in a PE of 30 - probably not - an assumed growth rate based on todays PE of 24% - maybe but not likely or EVEN just a measly 14% - yes of course.
Why should the company expect to grow more than 14% or wouldn't it, with the wholesale use of weight loss drugs be even less than 14%???